Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oliceridine Versus Sufentanil Analgesia for Postoperative Patients With Obstructive Sleep Apnea
Sponsor: Peking University First Hospital
Summary
Opioids are frequently used for postoperative analgesia but may induce side effects. Opioid-induced respiratory depression is the most dangerous side effect of opioids. Patients with obstructive sleep apnea (OSA) are at higher risk for opioid-induced respiratory depression. Oliceridine is a novel biased μ-opioid receptor agonist that selectively engages the G-protein pathway while reducing β-arrestin recruitment and thus may lower the risk of respiratory depression. The goal of this observational study is to compare the effects of oliceridine versus sufentanil analgesia on the incidence of postoperative respiratory depression in patients with known or suspected OSA in the postoperative period following elective surgery.
Official title: Effects of Oliceridine Versus Sufentanil Analgesia on Incidence of Postoperative Respiratory Depression in Patients at High-Risk of Obstructive Sleep Apnea: A Prospective Cohort Study
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
851
Start Date
2026-09
Completion Date
2029-12
Last Updated
2026-08-11
Healthy Volunteers
No
Interventions
Oliceridine
Oliceridine will be administered via patient-controlled intravenous analgesia.
Sufentanil
Sufentanil will be administered via patient-controlled intravenous analgesia.
Locations (1)
Peking University Fist Hospital
Beijing, China